FF · FutureFuel Corp.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $11.8M | second quarter of 2026 | — |
|
|
|||
| Biofuels capacity utilization | 56% | second quarter of 2026 | — |
| Biofuels segment production | 8.4M | second quarter of 2026 | — |
| Chemicals segment capacity utilization | 65% | second quarter of 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
FF
this stock
FutureFuel Corp.
|
$250.46M | +74.9% | -22.5% | — | 2.2% |
|
LIN
Linde PLC
|
$221.79B | +12.9% | +3.0% | 31.0 | 1.2% |
|
AIQUF
L Air Liquide SA /Fi
|
$123.27B | +3.2% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.98B | +7.1% | +2.1% | 31.9 | 2.6% |
|
ECL
Ecolab Inc.
|
$79.62B | +7.2% | +2.2% | 38.1 | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FF | -1.8% | +18.2% | +29.2% | +12.7% | +74.9% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +0.2% | +14.9% | +18.0% | +10.7% | +63.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.